trx0037
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2010 (NCT01253122)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Microtubule-associated protein tauINHIBITOR
MAPT inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trx0037
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01253499 | Phase 1 | Mar 1, 2010 | Quotient, TauRx Therapeutics Ltd |
| NCT01253122 | Phase 1 | Feb 1, 2010 | Quotient, TauRx Therapeutics Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Quotient | For profit | 2 | 0 | 1 | 2010 |
| TauRx Therapeutics Ltd | For profit | 2 | 2 | 1 | 2010 |
2 organizations
Page 1 / 1